Edgewise Therapeutics to Present at Wedbush PacGrow Healthcare Conference on August 11
Edgewise Therapeutics (NASDAQ: EWTX), a clinical-stage biopharmaceutical company, will participate in the virtual Wedbush PacGrow Healthcare Conference on August 11. Members of the management team will engage in a fireside chat at 3:30 PM ET, which will be streamed live and available for 90 days afterward. Edgewise specializes in developing innovative, orally bioavailable therapies for rare muscle disorders, leveraging its expertise in muscle biology and small molecule engineering to address significant unmet medical needs.
- None.
- None.
Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for rare muscle disorders, announced today that members of its management team will participate in a fireside chat and one-on-one investor meetings at the virtual Wedbush PacGrow Healthcare Conference on Wednesday, August 11.
The fireside chat will be webcast live at 3:30 pm ET; a link can be found on the Events and Presentations page under the investor relations section of Edgewise Therapeutic’s website at https://investors.edgewisetx.com/events-and-presentations and will be accessible for 90 days following the presentation. It is recommended that users connect to the webcast several minutes prior to the start to ensure a timely connection.
About Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Guided by its holistic drug discovery approach to targeting the muscle as an organ, Edgewise has combined its foundational expertise in muscle biology and small molecule engineering to build its proprietary, muscle focused drug discovery platform. Edgewise’s platform utilizes custom-built high throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases. To learn more, go to: www.edgewisetx.com or follow us on LinkedIn and Twitter.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210804005223/en/
FAQ
When is Edgewise Therapeutics participating in the Wedbush PacGrow Healthcare Conference?
What time will Edgewise's fireside chat start at the conference?
How can I access the fireside chat for Edgewise Therapeutics?
What is the focus of Edgewise Therapeutics' drug development?
What is the stock symbol for Edgewise Therapeutics?
